Indian newborns join global race to beat deadly drug-resistant sepsis
India has enrolled its first newborn in the global NeoSep1 trial at JIPMER, Puducherry. The study will test antibiotic combinations for neonatal sepsis as resistance weakens standard treatments.
26 Jun 10:46 · India Today